Side effects of GLP-1 medications

GLP-1 medications have become a familiar part of conversations about metabolic health, and along with the interest comes a very reasonable question: what are the side effects? Knowing what to expect — the common and usually manageable, the rare but serious, and the situations where these medicines should not be used at all — is part of making an informed decision. This explainer walks through the side-effect profile of GLP-1 medications in plain terms, so you can have a better conversation with a licensed clinician.

This is patient education, not medical advice. Only an independent licensed medical professional can decide whether any treatment is appropriate for you, and this article does not replace the guidance of your own clinician or the medication's labeling.

Common gastrointestinal side effects

The most familiar side effects of GLP-1 medications are gastrointestinal, and this makes sense given how the medicines work: they slow the rate at which the stomach empties and act on appetite. Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain, and some people also experience indigestion or reduced appetite that feels more pronounced than expected.

For many people, these effects are most noticeable early on or after a dose increase, and they often ease over time as the body adjusts. This is one of the reasons treatment in this class is typically started at a low dose and increased gradually — slow titration gives the body time to adapt and tends to keep side effects more manageable. It is also why “more, faster” is not a strategy here; pushing the dose up quickly usually means more side effects, not better results.

None of this means the effects are trivial. Nausea and other symptoms can genuinely affect daily life, and how a given person responds varies. The right response is not to tough it out in silence or to improvise with the dose, but to keep your clinician informed so that the plan can be adjusted thoughtfully.

It also helps to understand why the gastrointestinal effects cluster the way they do. Because the medication slows gastric emptying, food stays in the stomach longer, which can contribute to nausea, early fullness, and, for some people, constipation. Because appetite is reduced, some people eat and drink less without realising it, which can worsen constipation or dehydration if they are not paying attention. Recognising these connections makes the common-sense measures — smaller meals, steady hydration, gentle attention to fibre — feel less like arbitrary rules and more like a logical response to how the medicine works.

Serious warnings and contraindications

Alongside the common, usually mild effects, GLP-1 medications carry serious warnings that deserve careful attention. Most notably, these medications carry a boxed warning regarding thyroid C-cell tumors seen in rodent studies. A boxed warning is the FDA's most prominent safety warning, and it is the reason certain histories make these medicines inappropriate.

Specifically, people with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), should not use these medications. This is a firm contraindication, not a cautionary note to weigh — which is exactly why an evaluation asks about your personal and family medical history in detail.

Other serious risks call for caution and disclosure as well. These include pancreatitis (inflammation of the pancreas), gallbladder problems, and effects on the kidneys, particularly if dehydration develops from vomiting or diarrhea. Because these medicines are not recommended in pregnancy, it is important to tell a clinician if you are pregnant, planning to become pregnant, or breastfeeding. Allergic reactions, though uncommon, are also possible.

This is a large part of why an evaluation matters before starting treatment. A clinician needs to know your full personal and family history, the other medications you take, and any relevant conditions, because certain histories make these medicines unsuitable and certain combinations warrant caution. Being thorough and honest in that conversation is not a formality — it is how a serious safety decision gets made accurately on your behalf, and it is why starting an evaluation never guarantees that a particular medication will be prescribed.

How side effects are usually managed

The good news is that the common gastrointestinal effects are often manageable with a thoughtful approach, worked out with your clinician rather than alone. The foundation is the gradual dosing already described: starting low and increasing slowly gives the body time to adjust and is the single most effective way to limit side effects.

Beyond dosing, several practical measures are commonly discussed with patients:

• Eating smaller, slower meals, and stopping when comfortably full rather than overly full.
• Favouring blander, lower-fat foods when nausea is an issue, and easing back on very rich or greasy meals.
• Staying hydrated, which is especially important if you experience vomiting or diarrhea.
• Keeping your clinician informed, so the dose or timing can be adjusted if symptoms are persistent or difficult.

What you should not do is manage side effects by improvising with your prescription — changing the dose, skipping the schedule, or stretching supply on your own. Any adjustment belongs in a conversation with the clinician who prescribed it. This is also why an ongoing, supported relationship matters so much: side-effect management is part of the follow-up, not an afterthought.

A note on compounded versus FDA-approved products

Because GLP-1 medicines are available both as FDA-approved brands and as compounded preparations, one point is worth making explicitly. FDA-approved products — such as Ozempic® and Wegovy® (both semaglutide) and Mounjaro® and Zepbound™ (both tirzepatide) — have FDA-reviewed labeling that documents their side effects and warnings.

Compounded GLP-1 medications, by contrast, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality — though they may be prescribed by independent licensed physicians when clinically appropriate, such as during an FDA-declared shortage. The underlying active molecules share the same known side-effect considerations, but the regulatory status differs, and the two should never be blurred. This is another reason that who you obtain a medication through — a real evaluation, a licensed prescriber, a named licensed pharmacy — matters as much as the medicine itself. Our explainers on compounded semaglutide and compounded tirzepatide go further into that distinction.

What to realistically expect

Setting realistic expectations about side effects is as important as knowing the list. For many people, the early weeks — and the period just after each dose increase — are when gastrointestinal symptoms are most noticeable, and for many they settle as the body adapts. But this is a general pattern, not a promise: some people have very few side effects, others find them more troublesome, and a minority do not tolerate a particular medicine well. Individual responses vary, and no article can predict yours.

A responsible clinician frames this honestly rather than downplaying it. The aim is not to guarantee a smooth experience but to give you a clear picture, a gradual plan, and a way to reach someone if things are difficult. If a service glosses over side effects entirely, or presents the medicine as effortless, treat that as a reason for caution rather than reassurance — balanced information is a marker of a trustworthy service.

When to contact your clinician

Knowing when to reach out is one of the most useful things you can take from an article like this. Mild, easing gastrointestinal symptoms are common and usually expected, but certain symptoms warrant prompt contact with a clinician or, in an emergency, urgent medical care.

• Severe or persistent abdominal pain, especially pain that radiates to the back, which can be a sign of pancreatitis.
• Persistent vomiting or diarrhea, or any signs of dehydration such as marked dizziness or reduced urination.
• Symptoms of a serious allergic reaction, such as swelling, difficulty breathing, or a severe rash — seek emergency care.
• Signs of gallbladder trouble, such as upper-right abdominal pain, fever, or yellowing of the skin or eyes.
• Any new or worsening symptom that concerns you, even if it is not on a list — your clinician would rather hear from you.

The overarching principle is simple: when in doubt, ask. A responsible service is built around follow-up precisely so that you have somewhere to turn when something does not feel right. For general, non-commercial information, authoritative bodies such as the FDA (fda.gov) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) publish patient education worth reading alongside your clinician's advice, and you can browse related explainers in Weight Management.

The bottom line

The most common side effects of GLP-1 medications are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — and they are often mild and tend to ease as the body adjusts, especially with gradual dosing. More seriously, these medicines carry a boxed warning about thyroid C-cell tumors seen in rodents and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, with additional cautions around pancreatitis, gallbladder disease, kidney problems, and pregnancy. None of this can tell you whether a GLP-1 medication is right for you; only an evaluation with an independent licensed clinician can do that. Review the Important Safety Information below and bring your questions to that conversation.

Frequently asked questions